HRR Reference Standards – 28‑Gene Panel for Homologous Recombination Repair Research！
Comprehensive reference material covering key HRR genes with diverse mutation types and allele frequencies.
Product Center
Product Introduce
OHomologous Recombination Repair (HRR) – 28‑Gene Reference Standard.Homologous recombination repair (HRR) is a critical pathway for DNA double‑strand break repair. Defects in HRR genes (e.g., BRCA1, BRCA2, ATM, PALB2) lead to genomic instability and are associated with breast, ovarian, prostate, pancreatic, and other cancers. Patients with HRR deficiency often benefit from PARP inhibitors and platinum‑based therapies.
CB-Gene’s HRR‑Related 28‑Gene Reference Standard (CBP90021/CBP90044) is a well‑characterized, cell‑line‑derived cocktail that mimics clinical samples. It contains all 28 HRR pathway genes (as defined by the ARIEL3 study), each carrying mutations with diverse types: missense, nonsense, insertions, deletions, splice variants, and copy number variations. The standard includes clinically annotated variants (Benign, Likely Benign, VUS, Likely Pathogenic, Pathogenic) and a wide range of allele frequencies (from 1–5% near LoD to 50–100% high frequency). It is validated by 1000x WES, 3500x targeted NGS panel, and ddPCR for select sites.
Product Advantages
Our HRR Reference Standards simulate precise variant allele frequencies (VAFs) mirroring real clinical samples.
Comprehensive Coverage
28 HRR pathway genes including BRCA1, BRCA2, ATM, ATR, BARD1, BLM, BRIP1, CDK12, CHEK1, CHEK2, FANCA, FANCC, FANCD2, FANCF, FANCI, FANCL, FANCM, MRE11A, NBN, PALB2, PPP2R2A, RAD50, RAD51B, RAD51C, RAD51D, RAD52, RAD54L, and RPA1.
Diverse mutation types
Missense, nonsense, frameshift insertions/deletions, splice site variants, and synonymous variants.
Full clinical annotation spectrum
Includes Benign, Likely Benign, Uncertain Significance, Likely Pathogenic, and Pathogenic variants.
Wide allele frequency range
From ~1–5% (near LoD), through 10–50% (medium), up to 100% (high/ homozygous).
Multi‑platform validation
Characterized by 1000x WES, 3500x targeted NGS panel, and ddPCR for key sites.
Patent‑protected technology
Developed based on Cobioer’s patent “Standard for DNA Homologous Recombination Repair Gene Detection and Its Preparation Method”.
Application
Assay Sensitivity, Linearity & LoD Determination
Research Kit Optimization & Performance Validation
Daily Quality Control & Translational Research Integration
Company Advantage
Expertise in reference standards – CB-Gene specializes in oncology molecular diagnostics with ISO‑certified production and patented technology.
Scientific Quality Management
With our ISO9001 certification, we adhere to a stringent quality management system, ensuring that all our products meet the highest standards of accuracy, stability, and consistency.
Experienced and Skilled Team
Backed by a talented team of experts, we leverage advanced technology and extensive experience to drive innovation in molecular diagnostics, ensuring we stay at the forefront of the industry.
Comprehensive annotation
Includes benign to pathogenic variants, helping you evaluate real‑world assay performance.
Comprehensive Product Range
We offer a complete set of reference materials, including SNP, Indel, CNV, Fusion, NIPT, and more, covering a wide array of diagnostic needs and offering customized services for a variety of applications.
Contact Us
We're here to assist you! Whether you have questions about our products, services, or need technical support, our team is ready to provide you with the information you need. Reach out to us today!
FAQs
Related Blogs
PSMA IHC Control Standards for IHC Assay Development and Quality Control
PSMA IHC control standards are critical reference materials for prostate cancer pathological diagnosis and targeted therapy testing. Featuring positive/negative 2‑in‑1 FFPE tissue design, they support simultaneous positive control, negative control, background evaluation, and staining specificity verification. Suitable for assay development, inter‑batch reproducibility monitoring, routine QC, and external quality assessment.
Read More
How to Choose MSI Reference Standards for PCR-CE and NGS Assay Validation
For laboratories developing or validating microsatellite instability testing, choosing the right MSI reference standard is a critical step. MSI testing is not only about detecting instability.
Read More
What Is Microsatellite Instability? A Practical Guide to MSI Testing in Cancer Diagnostics
Microsatellite instability, commonly known as MSI, is a molecular change caused by defects in the DNA mismatch repair system. It occurs when short, repetitive DNA sequences called microsatellites become longer or shorter than normal due to insertion or deletion errors during DNA replication.
Read More
MSI Testing Methods Compared: IHC, PCR-CE and NGS for Detecting Microsatellite Instability
Microsatellite instability, commonly known as MSI, is an important molecular biomarker in oncology. It is closely associated with defects in the DNA mismatch repair system, also known as dMMR.
Read More
Get Touch With Us
Contact Info
Have questions or need assistance? We're here to help! Reach out to our team, and we'll provide the support you need.
